Associated Papers
Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3.
Islam MS et al.
Animals : an Open Access Journal From Mdpi, 2021
Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy.
Shiota M et al.
Urologic Oncology, 2020
Evaluation of 17β-hydroxysteroid dehydrogenase activity using androgen receptor-mediated transactivation.
Yazawa T et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2020
Assembling the jigsaw puzzle: CBX2 isoform 2 and its targets in disorders/differences of sex development.
Sproll P et al.
Molecular Genetics & Genomic Medicine, 2018
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.
Schrader A et al.
Nature Communications, 2018
Biochemical Analysis of Four Missense Mutations in the HSD17B3 Gene Associated With 46,XY Disorders of Sex Development in Egyptian Patients.
Engeli RT et al.
The Journal of Sexual Medicine, 2017
Novel cases of Tunisian patients with mutations in the gene encoding 17β-hydroxysteroid dehydrogenase type 3 and a founder effect.
Ben Rhouma B et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2017
Mutational Profile of 10 Afflicted Egyptian Families with 17-β-HSD-3 Deficiency.
Hassan HA et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation, 2016
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I et al.
Human Genomics, 2015
Molecular basis of non-syndromic hypospadias: systematic mutation screening and genome-wide copy-number analysis of 62 patients.
Kon M et al.
Human Reproduction (oxford, England), 2015
Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency.
Castro CC et al.
Arquivos Brasileiros De Endocrinologia E Metabologia, 2012
Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.
Kwon EM et al.
Cancer Epidemiology, 2012
Functional analyses of endometriosis-related polymorphisms in the estrogen synthesis and metabolism-related genes.
Wang HS et al.
Plos One, 2012
Genetic polymorphisms of 17 β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias.
Sata F et al.
The Journal of Sexual Medicine, 2010
The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency.
George MM et al.
Hormone Research in Paediatrics, 2010
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.
Sigurdson AJ et al.
Breast Cancer Research and Treatment, 2009
17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence.
Bertelloni S et al.
Journal of Endocrinological Investigation, 2009
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China.
Park SK et al.
Carcinogenesis, 2009
The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.
Vaarala MH et al.
International Journal of Cancer, 2008
17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite.
Mains LM et al.
Fertility and Sterility, 2008
Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.
Faienza MF et al.
Journal of Endocrinological Investigation, 2008
Variant in sex hormone-binding globulin gene and the risk of prostate cancer.
Berndt SI et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2007
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
Lindström S et al.
The Prostate, 2006
Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.
Mononen N et al.
Cancer Research, 2006
Androgen metabolic genes in prostate cancer predisposition and progression.
Makridakis NM et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2005
An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology.
Zhu Y et al.
Cancer Research, 2004
Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.
Margiotti K et al.
The Prostate, 2002
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations.
Boehmer AL et al.
The Journal of Clinical Endocrinology and Metabolism, 1999
Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3).
Moghrabi N et al.
The Journal of Clinical Endocrinology and Metabolism, 1998